Cargando…
P512: A PHASE 1B/2 STUDY OF TP-0903 AND DECITABINE TARGETING MUTANT TP53 AND/OR COMPLEX KARYOTYPE IN PATIENTS WITH UNTREATED ACUTE MYELOID LEUKEMIA (AML) ≥ AGE 60 YEARS: FINAL RESULTS
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428724/ http://dx.doi.org/10.1097/01.HS9.0000968956.29381.19 |
| _version_ | 1785090537731129344 |
|---|---|
| author | Mims, Alice Huang, Ying Eisenmann, Eric Orwick, Shelley Buelow, Daelynn Swords, Ronan Zeidner, Joshua Foster, Matthew L. Lin, Tara Baer, Maria Madanat, Yazan Kovacsovics, Tibor Redner, Robert Al-Mansour, Zeina Stefanos, Mona Martycz, Molly Druggan, Franchesca Chen, Timothy Yocum, Ashley Borate, Uma Druker, Brian Burd, Amy Levine, Ross Baker, Sharyn C. Byrd, John |
| author_facet | Mims, Alice Huang, Ying Eisenmann, Eric Orwick, Shelley Buelow, Daelynn Swords, Ronan Zeidner, Joshua Foster, Matthew L. Lin, Tara Baer, Maria Madanat, Yazan Kovacsovics, Tibor Redner, Robert Al-Mansour, Zeina Stefanos, Mona Martycz, Molly Druggan, Franchesca Chen, Timothy Yocum, Ashley Borate, Uma Druker, Brian Burd, Amy Levine, Ross Baker, Sharyn C. Byrd, John |
| author_sort | Mims, Alice |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428724 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104287242023-08-17 P512: A PHASE 1B/2 STUDY OF TP-0903 AND DECITABINE TARGETING MUTANT TP53 AND/OR COMPLEX KARYOTYPE IN PATIENTS WITH UNTREATED ACUTE MYELOID LEUKEMIA (AML) ≥ AGE 60 YEARS: FINAL RESULTS Mims, Alice Huang, Ying Eisenmann, Eric Orwick, Shelley Buelow, Daelynn Swords, Ronan Zeidner, Joshua Foster, Matthew L. Lin, Tara Baer, Maria Madanat, Yazan Kovacsovics, Tibor Redner, Robert Al-Mansour, Zeina Stefanos, Mona Martycz, Molly Druggan, Franchesca Chen, Timothy Yocum, Ashley Borate, Uma Druker, Brian Burd, Amy Levine, Ross Baker, Sharyn C. Byrd, John Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428724/ http://dx.doi.org/10.1097/01.HS9.0000968956.29381.19 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Mims, Alice Huang, Ying Eisenmann, Eric Orwick, Shelley Buelow, Daelynn Swords, Ronan Zeidner, Joshua Foster, Matthew L. Lin, Tara Baer, Maria Madanat, Yazan Kovacsovics, Tibor Redner, Robert Al-Mansour, Zeina Stefanos, Mona Martycz, Molly Druggan, Franchesca Chen, Timothy Yocum, Ashley Borate, Uma Druker, Brian Burd, Amy Levine, Ross Baker, Sharyn C. Byrd, John P512: A PHASE 1B/2 STUDY OF TP-0903 AND DECITABINE TARGETING MUTANT TP53 AND/OR COMPLEX KARYOTYPE IN PATIENTS WITH UNTREATED ACUTE MYELOID LEUKEMIA (AML) ≥ AGE 60 YEARS: FINAL RESULTS |
| title | P512: A PHASE 1B/2 STUDY OF TP-0903 AND DECITABINE TARGETING MUTANT TP53 AND/OR COMPLEX KARYOTYPE IN PATIENTS WITH UNTREATED ACUTE MYELOID LEUKEMIA (AML) ≥ AGE 60 YEARS: FINAL RESULTS |
| title_full | P512: A PHASE 1B/2 STUDY OF TP-0903 AND DECITABINE TARGETING MUTANT TP53 AND/OR COMPLEX KARYOTYPE IN PATIENTS WITH UNTREATED ACUTE MYELOID LEUKEMIA (AML) ≥ AGE 60 YEARS: FINAL RESULTS |
| title_fullStr | P512: A PHASE 1B/2 STUDY OF TP-0903 AND DECITABINE TARGETING MUTANT TP53 AND/OR COMPLEX KARYOTYPE IN PATIENTS WITH UNTREATED ACUTE MYELOID LEUKEMIA (AML) ≥ AGE 60 YEARS: FINAL RESULTS |
| title_full_unstemmed | P512: A PHASE 1B/2 STUDY OF TP-0903 AND DECITABINE TARGETING MUTANT TP53 AND/OR COMPLEX KARYOTYPE IN PATIENTS WITH UNTREATED ACUTE MYELOID LEUKEMIA (AML) ≥ AGE 60 YEARS: FINAL RESULTS |
| title_short | P512: A PHASE 1B/2 STUDY OF TP-0903 AND DECITABINE TARGETING MUTANT TP53 AND/OR COMPLEX KARYOTYPE IN PATIENTS WITH UNTREATED ACUTE MYELOID LEUKEMIA (AML) ≥ AGE 60 YEARS: FINAL RESULTS |
| title_sort | p512: a phase 1b/2 study of tp-0903 and decitabine targeting mutant tp53 and/or complex karyotype in patients with untreated acute myeloid leukemia (aml) ≥ age 60 years: final results |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428724/ http://dx.doi.org/10.1097/01.HS9.0000968956.29381.19 |
| work_keys_str_mv | AT mimsalice p512aphase1b2studyoftp0903anddecitabinetargetingmutanttp53andorcomplexkaryotypeinpatientswithuntreatedacutemyeloidleukemiaamlage60yearsfinalresults AT huangying p512aphase1b2studyoftp0903anddecitabinetargetingmutanttp53andorcomplexkaryotypeinpatientswithuntreatedacutemyeloidleukemiaamlage60yearsfinalresults AT eisenmanneric p512aphase1b2studyoftp0903anddecitabinetargetingmutanttp53andorcomplexkaryotypeinpatientswithuntreatedacutemyeloidleukemiaamlage60yearsfinalresults AT orwickshelley p512aphase1b2studyoftp0903anddecitabinetargetingmutanttp53andorcomplexkaryotypeinpatientswithuntreatedacutemyeloidleukemiaamlage60yearsfinalresults AT buelowdaelynn p512aphase1b2studyoftp0903anddecitabinetargetingmutanttp53andorcomplexkaryotypeinpatientswithuntreatedacutemyeloidleukemiaamlage60yearsfinalresults AT swordsronan p512aphase1b2studyoftp0903anddecitabinetargetingmutanttp53andorcomplexkaryotypeinpatientswithuntreatedacutemyeloidleukemiaamlage60yearsfinalresults AT zeidnerjoshua p512aphase1b2studyoftp0903anddecitabinetargetingmutanttp53andorcomplexkaryotypeinpatientswithuntreatedacutemyeloidleukemiaamlage60yearsfinalresults AT fostermatthew p512aphase1b2studyoftp0903anddecitabinetargetingmutanttp53andorcomplexkaryotypeinpatientswithuntreatedacutemyeloidleukemiaamlage60yearsfinalresults AT llintara p512aphase1b2studyoftp0903anddecitabinetargetingmutanttp53andorcomplexkaryotypeinpatientswithuntreatedacutemyeloidleukemiaamlage60yearsfinalresults AT baermaria p512aphase1b2studyoftp0903anddecitabinetargetingmutanttp53andorcomplexkaryotypeinpatientswithuntreatedacutemyeloidleukemiaamlage60yearsfinalresults AT madanatyazan p512aphase1b2studyoftp0903anddecitabinetargetingmutanttp53andorcomplexkaryotypeinpatientswithuntreatedacutemyeloidleukemiaamlage60yearsfinalresults AT kovacsovicstibor p512aphase1b2studyoftp0903anddecitabinetargetingmutanttp53andorcomplexkaryotypeinpatientswithuntreatedacutemyeloidleukemiaamlage60yearsfinalresults AT rednerrobert p512aphase1b2studyoftp0903anddecitabinetargetingmutanttp53andorcomplexkaryotypeinpatientswithuntreatedacutemyeloidleukemiaamlage60yearsfinalresults AT almansourzeina p512aphase1b2studyoftp0903anddecitabinetargetingmutanttp53andorcomplexkaryotypeinpatientswithuntreatedacutemyeloidleukemiaamlage60yearsfinalresults AT stefanosmona p512aphase1b2studyoftp0903anddecitabinetargetingmutanttp53andorcomplexkaryotypeinpatientswithuntreatedacutemyeloidleukemiaamlage60yearsfinalresults AT martyczmolly p512aphase1b2studyoftp0903anddecitabinetargetingmutanttp53andorcomplexkaryotypeinpatientswithuntreatedacutemyeloidleukemiaamlage60yearsfinalresults AT drugganfranchesca p512aphase1b2studyoftp0903anddecitabinetargetingmutanttp53andorcomplexkaryotypeinpatientswithuntreatedacutemyeloidleukemiaamlage60yearsfinalresults AT chentimothy p512aphase1b2studyoftp0903anddecitabinetargetingmutanttp53andorcomplexkaryotypeinpatientswithuntreatedacutemyeloidleukemiaamlage60yearsfinalresults AT yocumashley p512aphase1b2studyoftp0903anddecitabinetargetingmutanttp53andorcomplexkaryotypeinpatientswithuntreatedacutemyeloidleukemiaamlage60yearsfinalresults AT borateuma p512aphase1b2studyoftp0903anddecitabinetargetingmutanttp53andorcomplexkaryotypeinpatientswithuntreatedacutemyeloidleukemiaamlage60yearsfinalresults AT drukerbrian p512aphase1b2studyoftp0903anddecitabinetargetingmutanttp53andorcomplexkaryotypeinpatientswithuntreatedacutemyeloidleukemiaamlage60yearsfinalresults AT burdamy p512aphase1b2studyoftp0903anddecitabinetargetingmutanttp53andorcomplexkaryotypeinpatientswithuntreatedacutemyeloidleukemiaamlage60yearsfinalresults AT levineross p512aphase1b2studyoftp0903anddecitabinetargetingmutanttp53andorcomplexkaryotypeinpatientswithuntreatedacutemyeloidleukemiaamlage60yearsfinalresults AT bakersharyn p512aphase1b2studyoftp0903anddecitabinetargetingmutanttp53andorcomplexkaryotypeinpatientswithuntreatedacutemyeloidleukemiaamlage60yearsfinalresults AT cbyrdjohn p512aphase1b2studyoftp0903anddecitabinetargetingmutanttp53andorcomplexkaryotypeinpatientswithuntreatedacutemyeloidleukemiaamlage60yearsfinalresults |